Results of the multivariable propensity score adjusted analysis comparing primary care physician vs. cardiology follow-up for the primary (all-cause mortality) and secondary (composite of death or major adverse events) endpoint
. | Comparison cardiology vs primary physician follow-up . | |||
---|---|---|---|---|
Number of events . | Hazard ratio . | 95% CI . | P-value . | |
All-cause mortality | ||||
Overall cohort (n = 23 879) | 520 | 0.81 | 0.67–0.98 | 0.03 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 314 | 0.96 | 0.74–1.24 | 0.75 |
Female sex (n = 13 165) | 206 | 0.65 | 0.48–0.88 | 0.005 |
Age group <45 years (n = 12 326) | 91 | 0.93 | 0.58–1.5 | 0.77 |
Age group 45–70 years (n = 11 553) | 429 | 0.76 | 0.62–0.94 | 0.01 |
Moderate or high complexity cardiac lesion (n = 7324) | 210 | 0.73 | 0.53–0.997 | 0.048 |
Simple cardiac lesion (n = 16 555) | 310 | 0.85 | 0.66–1.09 | 0.19 |
All-cause mortality or major adverse event | ||||
Overall cohort (n = 23 879) | 2491 | 0.85 | 0.78–0.92 | <0.001 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 1350 | 0.82 | 0.73–0.93 | 0.001 |
Female sex (n = 13 165) | 1141 | 0.88 | 0.77–0.998 | 0.046 |
Age group <45 years (n = 12 326) | 703 | 0.99 | 0.84–1.17 | 0.91 |
Age group 45–70 years (n = 11 553) | 1788 | 0.77 | 0.70–0.85 | <0.001 |
Moderate or high complexity cardiac lesion (n = 7324) | 872 | 0.81 | 0.70–0.94 | 0.007 |
Simple cardiac lesion (n = 16 555) | 1619 | 0.85 | 0.77–0.95 | 0.003 |
. | Comparison cardiology vs primary physician follow-up . | |||
---|---|---|---|---|
Number of events . | Hazard ratio . | 95% CI . | P-value . | |
All-cause mortality | ||||
Overall cohort (n = 23 879) | 520 | 0.81 | 0.67–0.98 | 0.03 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 314 | 0.96 | 0.74–1.24 | 0.75 |
Female sex (n = 13 165) | 206 | 0.65 | 0.48–0.88 | 0.005 |
Age group <45 years (n = 12 326) | 91 | 0.93 | 0.58–1.5 | 0.77 |
Age group 45–70 years (n = 11 553) | 429 | 0.76 | 0.62–0.94 | 0.01 |
Moderate or high complexity cardiac lesion (n = 7324) | 210 | 0.73 | 0.53–0.997 | 0.048 |
Simple cardiac lesion (n = 16 555) | 310 | 0.85 | 0.66–1.09 | 0.19 |
All-cause mortality or major adverse event | ||||
Overall cohort (n = 23 879) | 2491 | 0.85 | 0.78–0.92 | <0.001 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 1350 | 0.82 | 0.73–0.93 | 0.001 |
Female sex (n = 13 165) | 1141 | 0.88 | 0.77–0.998 | 0.046 |
Age group <45 years (n = 12 326) | 703 | 0.99 | 0.84–1.17 | 0.91 |
Age group 45–70 years (n = 11 553) | 1788 | 0.77 | 0.70–0.85 | <0.001 |
Moderate or high complexity cardiac lesion (n = 7324) | 872 | 0.81 | 0.70–0.94 | 0.007 |
Simple cardiac lesion (n = 16 555) | 1619 | 0.85 | 0.77–0.95 | 0.003 |
Data are provided for the overall cohort as well as for predefined subgroups of patients. A HR <1 indicates superior survival/freedom from adverse events for the group with cardiology follow-up. Details on the definition of the composite endpoint as well as variables included in the propensity score/multivariable analysis are given in the Methods section as well as Supplementary material online, Table S1. Text in bold identifies significant parameters.
Results of the multivariable propensity score adjusted analysis comparing primary care physician vs. cardiology follow-up for the primary (all-cause mortality) and secondary (composite of death or major adverse events) endpoint
. | Comparison cardiology vs primary physician follow-up . | |||
---|---|---|---|---|
Number of events . | Hazard ratio . | 95% CI . | P-value . | |
All-cause mortality | ||||
Overall cohort (n = 23 879) | 520 | 0.81 | 0.67–0.98 | 0.03 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 314 | 0.96 | 0.74–1.24 | 0.75 |
Female sex (n = 13 165) | 206 | 0.65 | 0.48–0.88 | 0.005 |
Age group <45 years (n = 12 326) | 91 | 0.93 | 0.58–1.5 | 0.77 |
Age group 45–70 years (n = 11 553) | 429 | 0.76 | 0.62–0.94 | 0.01 |
Moderate or high complexity cardiac lesion (n = 7324) | 210 | 0.73 | 0.53–0.997 | 0.048 |
Simple cardiac lesion (n = 16 555) | 310 | 0.85 | 0.66–1.09 | 0.19 |
All-cause mortality or major adverse event | ||||
Overall cohort (n = 23 879) | 2491 | 0.85 | 0.78–0.92 | <0.001 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 1350 | 0.82 | 0.73–0.93 | 0.001 |
Female sex (n = 13 165) | 1141 | 0.88 | 0.77–0.998 | 0.046 |
Age group <45 years (n = 12 326) | 703 | 0.99 | 0.84–1.17 | 0.91 |
Age group 45–70 years (n = 11 553) | 1788 | 0.77 | 0.70–0.85 | <0.001 |
Moderate or high complexity cardiac lesion (n = 7324) | 872 | 0.81 | 0.70–0.94 | 0.007 |
Simple cardiac lesion (n = 16 555) | 1619 | 0.85 | 0.77–0.95 | 0.003 |
. | Comparison cardiology vs primary physician follow-up . | |||
---|---|---|---|---|
Number of events . | Hazard ratio . | 95% CI . | P-value . | |
All-cause mortality | ||||
Overall cohort (n = 23 879) | 520 | 0.81 | 0.67–0.98 | 0.03 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 314 | 0.96 | 0.74–1.24 | 0.75 |
Female sex (n = 13 165) | 206 | 0.65 | 0.48–0.88 | 0.005 |
Age group <45 years (n = 12 326) | 91 | 0.93 | 0.58–1.5 | 0.77 |
Age group 45–70 years (n = 11 553) | 429 | 0.76 | 0.62–0.94 | 0.01 |
Moderate or high complexity cardiac lesion (n = 7324) | 210 | 0.73 | 0.53–0.997 | 0.048 |
Simple cardiac lesion (n = 16 555) | 310 | 0.85 | 0.66–1.09 | 0.19 |
All-cause mortality or major adverse event | ||||
Overall cohort (n = 23 879) | 2491 | 0.85 | 0.78–0.92 | <0.001 |
Subgroup analyses | ||||
Male sex (n = 10 714) | 1350 | 0.82 | 0.73–0.93 | 0.001 |
Female sex (n = 13 165) | 1141 | 0.88 | 0.77–0.998 | 0.046 |
Age group <45 years (n = 12 326) | 703 | 0.99 | 0.84–1.17 | 0.91 |
Age group 45–70 years (n = 11 553) | 1788 | 0.77 | 0.70–0.85 | <0.001 |
Moderate or high complexity cardiac lesion (n = 7324) | 872 | 0.81 | 0.70–0.94 | 0.007 |
Simple cardiac lesion (n = 16 555) | 1619 | 0.85 | 0.77–0.95 | 0.003 |
Data are provided for the overall cohort as well as for predefined subgroups of patients. A HR <1 indicates superior survival/freedom from adverse events for the group with cardiology follow-up. Details on the definition of the composite endpoint as well as variables included in the propensity score/multivariable analysis are given in the Methods section as well as Supplementary material online, Table S1. Text in bold identifies significant parameters.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.